Liana Billings

Lead author of the EloraTZP phase 2 study, Endeavor Health (US)

Press citations per month · linked articles

Oct 2026Nov 2026to date

press citation on 1 topic since 1 Oct 2026 · last quoted 1 Oct 2026

02 Quoted on · 1 of 29 topics

Diabetes1

Open the topic

Liana Billings: key facts

Kind of voice: Academic
Role: Lead author of the EloraTZP phase 2 study, Endeavor Health (US)
Quoted on: Diabetes
Tracked press citations: 1
Most recently quoted: 1 Oct 2026

03 Profile

04 On the record · press

What Liana Billings has said

By outlet · linked articles

pharmaphorum.com1

Where Liana Billings has been quoted

01New Lilly combo tops tirzepatide for weight loss in diabetespharmaphorum.com · 1 Oct 2026

Verbatim

“Obesity and type 2 diabetes are interconnected, and we are seeing the potential benefit of targeting multiple hormonal pathways to address both”

Lead author of the EloraTZP phase 2 study, Endeavor Health (US) · Diabetes · pharmaphorum.com · 1 Oct 2026 · Read the article

Related media coverage

Recent UK press coverage of their topics, not necessarily citing them directly.

First UK patient treated with NICE approved TeplizumabUniversity of Birmingham
Branding update for insulin pensDiabetes Research & Wellness Foundation
DRWF Events: Register now for Diabetes: A Whole Life BlueprintDiabetes Research & Wellness Foundation

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.